X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ASTRAZENECA PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ASTRAZENECA PHARMA J.B.CHEMICALS/
ASTRAZENECA PHARMA
 
P/E (TTM) x 13.8 90.6 15.2% View Chart
P/BV x 2.2 12.9 16.9% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
ASTRAZENECA PHARMA
Mar-14
J.B.CHEMICALS/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs3181,285 24.8%   
Low Rs200634 31.5%   
Sales per share (Unadj.) Rs148.0189.6 78.1%  
Earnings per share (Unadj.) Rs19.1-0.2 -9,373.3%  
Cash flow per share (Unadj.) Rs23.93.8 622.9%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.968.6 187.9%  
Shares outstanding (eoy) m84.8225.00 339.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.75.1 34.6%   
Avg P/E ratio x13.6-4,712.7 -0.3%  
P/CF ratio (eoy) x10.8249.6 4.3%  
Price / Book Value ratio x2.014.0 14.4%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,95123,988 91.5%   
No. of employees `0002.71.6 175.4%   
Total wages/salary Rs m1,8411,605 114.7%   
Avg. sales/employee Rs Th4,590.93,040.2 151.0%   
Avg. wages/employee Rs Th673.41,029.2 65.4%   
Avg. net profit/employee Rs Th592.1-3.3 -18,134.2%   
INCOME DATA
Net Sales Rs m12,5514,740 264.8%  
Other income Rs m54292 588.1%   
Total revenues Rs m13,0934,832 271.0%   
Gross profit Rs m2,055-130 -1,583.0%  
Depreciation Rs m412101 407.5%   
Interest Rs m960-   
Profit before tax Rs m2,088-139 -1,503.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m4695 9,215.9%   
Profit after tax Rs m1,619-5 -31,801.8%  
Gross profit margin %16.4-2.7 -597.8%  
Effective tax rate %22.5-3.7 -613.0%   
Net profit margin %12.9-0.1 -12,009.1%  
BALANCE SHEET DATA
Current assets Rs m7,7782,726 285.3%   
Current liabilities Rs m4,3582,435 179.0%   
Net working cap to sales %27.26.1 443.1%  
Current ratio x1.81.1 159.4%  
Inventory Days Days5574 74.1%  
Debtors Days Days8041 196.3%  
Net fixed assets Rs m5,7131,035 551.8%   
Share capital Rs m17050 339.2%   
"Free" reserves Rs m10,547942 1,119.1%   
Net worth Rs m10,9371,716 637.4%   
Long term debt Rs m00-   
Total assets Rs m15,5744,156 374.7%  
Interest coverage x22.8NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.81.1 70.7%   
Return on assets %11.0-0.1 -8,988.2%  
Return on equity %14.8-0.3 -4,989.5%  
Return on capital %20.00-  
Exports to sales %48.75.7 854.6%   
Imports to sales %7.16.5 109.6%   
Exports (fob) Rs m6,115270 2,263.1%   
Imports (cif) Rs m889306 290.1%   
Fx inflow Rs m6,169375 1,646.8%   
Fx outflow Rs m1,285470 273.3%   
Net fx Rs m4,884-96 -5,111.3%   
CASH FLOW
From Operations Rs m1,397-8 -17,243.2%  
From Investments Rs m-320-146 219.8%  
From Financial Activity Rs m-1,196862 -138.7%  
Net Cashflow Rs m-102709 -14.4%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 75.0 0.4%  
Indian inst/Mut Fund % 3.4 0.3 1,130.0%  
FIIs % 3.9 15.7 24.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 9.1 406.6%  
Shareholders   30,437 12,856 236.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   WOCKHARDT LTD.  FULFORD INDIA  MERCK LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 22, 2017 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS